HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jinming Zhang Selected Research

Glycyrrhetinic Acid (Po 12)

1/2021Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor.
1/2020Dietary compound glycyrrhetinic acid suppresses tumor angiogenesis and growth by modulating antiangiogenic and proapoptotic pathways in vitro and in vivo.
1/2016Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.
10/2015Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
9/2015Glycyrrhetinic acid-decorated and reduction-sensitive micelles for targeted cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jinming Zhang Research Topics

Disease

60Neoplasms (Cancer)
09/2022 - 06/2002
16Inflammation (Inflammations)
06/2022 - 10/2013
12Ulcerative Colitis
05/2022 - 01/2018
12Breast Neoplasms (Breast Cancer)
11/2021 - 09/2014
11Neoplasm Metastasis (Metastasis)
06/2021 - 06/2002
9Hepatocellular Carcinoma (Hepatoma)
03/2022 - 10/2013
8Lung Neoplasms (Lung Cancer)
01/2022 - 01/2012
6Cognitive Dysfunction
01/2022 - 08/2015
6Colitis
09/2021 - 02/2020
5Prostatic Neoplasms (Prostate Cancer)
06/2022 - 01/2020
5Fibrosis (Cirrhosis)
03/2022 - 01/2021
5Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2011
5Liver Neoplasms (Liver Cancer)
01/2020 - 01/2015
4Diarrhea
05/2022 - 01/2019
4Infections
02/2022 - 04/2016
4Wounds and Injuries (Trauma)
12/2020 - 06/2012
3Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
06/2022 - 02/2013
3Arthritis (Polyarthritis)
03/2022 - 06/2021
3Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2022 - 01/2021
3Colonic Neoplasms (Colon Cancer)
01/2022 - 01/2019
3Osteoarthritis
11/2021 - 01/2015
3Glioma (Gliomas)
01/2021 - 12/2018
3Pain (Aches)
11/2020 - 01/2015
3Carcinogenesis
12/2019 - 01/2013
3Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 11/2009
3Parkinson Disease (Parkinson's Disease)
02/2017 - 05/2008
3Obesity
04/2016 - 01/2013
2Rheumatoid Arthritis
03/2022 - 06/2021
2Cardiotoxicity
01/2022 - 01/2019
2Asthma (Bronchial Asthma)
01/2022 - 09/2018
2Memory Disorders (Memory Loss)
09/2021 - 01/2020
2Thrombophilia
01/2021 - 01/2020
2Carcinoma (Carcinomatosis)
01/2021 - 11/2017

Drug/Important Bio-Agent (IBA)

15Pharmaceutical PreparationsIBA
09/2021 - 01/2012
11CytokinesIBA
05/2022 - 01/2013
9Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2016
7MicellesIBA
11/2017 - 09/2014
6Biological ProductsIBA
01/2022 - 11/2009
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 01/2016
6Biomarkers (Surrogate Marker)IBA
12/2021 - 08/2017
5AntigensIBA
06/2022 - 01/2018
5Therapeutic UsesIBA
05/2022 - 05/2015
5LigandsIBA
03/2022 - 11/2012
5Glycyrrhetinic Acid (Po 12)IBA
01/2021 - 09/2015
5Polylactic Acid-Polyglycolic Acid CopolymerIBA
11/2017 - 12/2014
4PhytochemicalsIBA
09/2022 - 01/2013
4AntioxidantsIBA
01/2022 - 09/2018
4HydrogelsIBA
07/2021 - 01/2019
4Hyaluronic Acid (Hyaluronan)IBA
07/2021 - 02/2016
4PolymersIBA
06/2021 - 01/2016
4DisulfidesIBA
01/2021 - 10/2015
4Polysaccharides (Glycans)IBA
09/2019 - 03/2007
3AcidsIBA
06/2022 - 10/2018
3rheinIBA
05/2022 - 01/2021
3Interleukin-6 (Interleukin 6)IBA
03/2022 - 08/2017
3Dextran SulfateIBA
01/2022 - 01/2018
3Liposomes (Liposome)IBA
11/2021 - 01/2012
3triptolideIBA
11/2021 - 11/2020
3DNA (Deoxyribonucleic Acid)IBA
11/2021 - 06/2017
3CurcuminIBA
09/2021 - 01/2017
3Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 01/2017
3Ethanol (Ethyl Alcohol)IBA
01/2021 - 01/2018
3MicroRNAs (MicroRNA)IBA
01/2021 - 02/2016
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2020 - 09/2019
32- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2020 - 01/2011
3Amyloid (Amyloid Fibrils)IBA
01/2020 - 08/2015
3PhosphatidylserinesIBA
01/2020 - 12/2018
3Peptides (Polypeptides)IBA
11/2017 - 01/2016
3LipidsIBA
01/2017 - 01/2016
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
09/2022 - 01/2017
2shentong zhuyuIBA
03/2022 - 06/2021
2Interleukin-17 (Interleukin 17)IBA
03/2022 - 12/2021
2Antineoplastic Agents (Antineoplastics)IBA
03/2022 - 01/2014
2Monoclonal AntibodiesIBA
03/2022 - 01/2021
2Bleomycin (Blenoxane)FDA LinkGeneric
03/2022 - 01/2021
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2022 - 01/2018
2Sorafenib (BAY 43-9006)FDA Link
01/2022 - 01/2016
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 02/2017
2andrographolideIBA
01/2022 - 01/2020
2EstersIBA
01/2022 - 06/2021
2oxalyldiaminopropionic acidIBA
01/2022 - 01/2022
2Urea (Carbamide)FDA LinkGeneric
01/2022 - 01/2022
2FlavonoidsIBA
12/2021 - 10/2013
2celastrolIBA
11/2021 - 01/2020
2PectinsIBA
11/2021 - 07/2021
2ZeinIBA
09/2021 - 07/2021
2Toll-Like Receptor 4IBA
09/2021 - 01/2015
2Irinotecan (Camptosar)FDA LinkGeneric
08/2021 - 01/2019
2gegenqinlianIBA
08/2021 - 01/2019
2Indicators and Reagents (Reagents)IBA
07/2021 - 01/2021
2tetrandrineIBA
01/2021 - 01/2017
2Thymidine Monophosphate (TMP)IBA
01/2021 - 01/2019

Therapy/Procedure

28Therapeutics
09/2022 - 10/2013
10Drug Therapy (Chemotherapy)
09/2022 - 01/2012
8Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 05/2015
5Radiotherapy
06/2022 - 09/2013
4Oral Administration
09/2021 - 01/2020
3Immunomodulation
12/2021 - 03/2007
2Lymph Node Excision (Lymph Node Dissection)
11/2022 - 10/2015
2Thyroidectomy
11/2022 - 01/2022